. . . . . . . "[The pro-inflammatory cytokine interleukin (IL)-1? is a clinical target in many conditions involving dysregulation of the immune system; therapeutics that block IL-1? have been approved to treat diseases such as rheumatoid arthritis (RA), neonatal onset multisystem inflammatory diseases, cryopyrin-associated periodic syndromes, active systemic juvenile idiopathic arthritis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:13:43+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .